Just 17 years ago, the human genome was first sequenced at a price of $300 million. Today, companies are furiously trying to get this down to a hundred bucks per sequence. Panelists will discuss the latest attempts, the current challenges, and the timeline for bringing the genome into every doctor’s office.
Moderator: Meg Tirrell, Reporter, CNBC
Cindy Collins, CEO, Human Longevity, Inc.
Chris Cournoyer, CEO, N-of-One, Inc.
Charis Eng, MD, PhD, Chair, Genomic Medicine Institute, Cleveland Clinic
Alexander Ford, President, Myriad Genetic Laboratories, Inc.
Learn how Cleveland Clinic Innovations translates the ideas of its caregivers into patient-benefiting products and companies. Speakers will highlight the unique relationships CCI has forged to scale its innovative culture, and discuss how the Clinic is investing in and leveraging Cleveland’s surging biomedical industry.
Moderator: Peter O’Neill, Executive Director, Cleveland Clinic Innovations
Jerry Frantz, Senior Managing Partner, Entrepreneurial Services & Investing, JumpStart
Ryan Kelly, General Manager, Innovation Lab
Mark Waugh, Technology & Strategic Marketing Manager. Murata Electronics
Does your leadership style foster innovation? How would you answer? Gain insights from this panel of top leaders and presenters.
Moderator: Linda McHugh, Chief Human Resources Officer, Cleveland Clinic
Andre Machado, MD, PhD, Chair, Neurological Institute, Cleveland Clinic
Margaret McKenzie, MD, President, South Pointe Hospital
Kristen Morris, Chief Government Relations Officer, Cleveland Clinic
Andrea Sikon, MD, Chair, Internal Medicine and Geriatrics, Cleveland Clinic
Keynote: Jennifer Lee, MD, Deputy Under Secretary for Health for Policy & Services, Veterans Affairs
Keynote: Implementing Precision Medicine: Eric Green, MD, PhD, Director, NIH National Human Genome Research Institute
Starting with the launch of the Human Genome Project in 1990, the field of genomics has brought spectacular advances to empower the study of human biology and disease. In recent years, clinical applications of genomics have begun to emerge, ushering in the era of genomic medicine.
There is no question that cancer is a key priority for U.S. companies, research institutes, and government agencies. While collaborative efforts are underway, we often can’t help but wonder whether it will be enough. Experts on this panel will discuss the latest government investments and the policies needed to push cancer to its tipping point.
Moderator: Reed Tuckson, MD, Managing Director, Tuckson Health Connections, LLC
Anna Abram, Deputy Commissioner,, FDA
Brian Bolwell, MD, Chair, Taussig Cancer Institute, Cleveland Clinic
Eric Green MD, PhD, Director, National Human Genome Research Institute, NIH
Jennifer Lee, MD, Deputy Under Secretary for Health for Policy & Services, Veterans Affairs
In 2014, Cleveland Clinic partnered with Vizient to develop a new type of sourcing model based on clinical evidence and led by physicians to facilitate product decision making. This session will identify Cleveland Clinic's journey to developing a physician-led sourcing model and process supported by a supply cost analytics tool to align physicians around clinical and cost priorities.
David Gurd, MD, Head of Pediatric Spinal Deformity Surgery and Medical Director, Supply Chain Management, Cleveland Clinic, and Medical Director, Excelerate
Simrit Sandhu, Executive Director, Supply Chain Management, Cleveland Clinic
Tapped to lead time and time again, Jan Murphy generously shares her story of success as a serving leader at Cleveland Clinic.
Jan Murphy, RN, COO, Regional Hospitals & Family Health Centers, Cleveland Clinic
Known for a culture built on strong core values, Boston Scientific continues to innovate with its product and services as well as in its relationship with the broader healthcare system. Boston Scientific CEO Mike Mahoney joins Dr. Delos Cosgrove for a candid conversation on a range of topics, from the challenges and opportunities facing the device industry to the role of devices in precision medicine, and how the company fosters innovation across the 27,000-employee enterprise.
Mike Mahoney, President & CEO, Boston Scientific
Moderator: Delos Cosgrove, MD, CEO & President, Cleveland Clinic
In a new era of value-based technology, the need to demonstrate outcomes is becoming critical. The medical device industry in particular is showing signs of abandoning its one-size-fits-all mentality in favor of a hyper-precise methodology that accounts for the unique needs of the individual. This panel will discuss how the biggest players in the industry are investing in this new market, and give a glimpse of some novel technologies that are leading this new charge.
Moderator: Wael Barsoum, MD, President, Cleveland Clinic Florida
Gary Guthart, PhD, President & CEO, Intuitive Surgical
Kevin Lobo, Chairman & CEO, Stryker
Rakesh Mehta, Managing Director, J.P. Morgan
Hear from opera singer and double lung transplant recipient.
Charity Tillemann-Dick, an American-born soprano and top-selling classical recording artist
At a time when the future of healthcare is at the center of debate over public policy in the United States, “it’s essential that innovation remain at the core in the delivery of medical care,” Susan Bernat, general manager of strategic marketing at the world-renowned Cleveland Clinic told Convene.
An opera singer who underwent two double-lung transplants had the performance of a lifetime as she shared the stage with her donor's daughter.
An insulin pump that functions like an artificial pancreas ranked No. 1 on Cleveland Clinic's list of the Top 10 Medical Innovations for 2018. The announcement of the entire list will be made Wednesday as part of the Cleveland Clinic Medical Innovation Summit.
A panel of nearly 100 Cleveland Clinic doctors and scientist selected the 10 innovations from more than 150 nominations.
A team of Case Western Reserve University students' idea for wearable tech to monitor heart patients won the recent Cleveland Medical Hackathon.
An emerging company that uses vision technology to predict and help prevent the development of Alzheimer’s won “The Challenge” during the Medical Innovation Summit in Cleveland.
Genomics expert J. Craig Venter doesn’t mind scaring people by giving alarming statistics on death.
Forty percent of men and 24 percent of women between the ages of 50 to 74 years old in the United States will not reach the age of 75. A third will die of cardiovascular disease and another third from cancer, Venter said Monday at the Medical Innovation Summit.
Augmented reality goggles that allow surgeons to see a 3-D image of their patient's organs will soon be used. And, physicians will use a medical device similar to a GPS to navigate surgical tools through a patient's circulatory system.
The Cleveland Clinic is holding its annual Medical Innovation Summit this week. One speaker who took the stage is soprano Charity Tillemann-Dick. She received two double-lung transplants at the Clinic and has gone on to perform across the United States, Europe and Asia.
Across the country, hospitals are struggling to do more with less. Rising costs for pharmaceuticals and medical supplies are making healthcare more expensive and leaving healthcare providers searching for ways to care for patients without going into the red.